Thursday, April 21, 2016
Jan Tesarik, M.D., Ph.D., Raquel Mendoza-Tesarik, Ph.D., Nicolas Mendoza, M.D.…
Monday, March 30, 2015
We describe two luteal phase support protocols after gonadotropin-releasing hormone agonist trigger: the European and the American approaches. Both concepts facilitate fresh embryo transfer with excellent reproductive outcomes in the ovarian hyperstimulation syndrome–risk patient.
Friday, January 30, 2015
This meta-analysis suggests that estradiol addition during the luteal phase does not improve in vitro fertilization/intracytoplasmic sperm injection outcomes through oral medication, even with different daily doses.
Thursday, February 20, 2014
This editorial focuses on frozen embryo transfer (FET) or donor oocyte embryo transfer where hormonal therapy is used for endometrial preparation and no functional corpus luteum is present.
Tuesday, December 31, 2013
Luteal phase supportwith a newsubcutaneous progesterone preparation provided pregnancy rates similar to progesterone vaginal gel in IVF patients. Safety and tolerability profile were equivalent.
Friday, August 30, 2013
In mock donor-egg assisted reproduction technology cycles, daily subcutaneous administration of 25 mg or 50 mg progesterone reproduces the physiologic secretory transformation of the endometrium seen in the luteal phase.
Tuesday, April 30, 2013
Luteal supplementation with a weekly progesterone vaginal ring or daily vaginal gel provided similar high clinical pregnancy rates in in vitro fertilization.
Wednesday, January 2, 2013
Endometrin monotherapy provided comparable pregnancy rates (PRs) in fresh autologous and fresh donor oocyte cycles. The addition of P in oil to endometrin improved PRs in frozen transfer cycles.
Thursday, November 29, 2012
Luteal support with 8% Crinone was associated with lower odds of clinical pregnancy and live birth compared with intramuscular progesterone in a multivariable analysis of day 3 cryopreserved embryo transfer cycles.
Wednesday, May 30, 2012
Dual trigger with GnRH agonist and low-dose hCG in high responders with peak E2 levels <4,000 pg/mL improves live birth rates.
Friday, May 25, 2012
In younger patients undergoing IVF, luteal phase support with vaginal P produces significantly higher pregnancy rates than does IMP. Vaginal P is equally effective as IM in older patients.
Tuesday, May 22, 2012
Intensive luteal phase support is effective in improving pregnancy rates after GnRHa trigger.